Form 4: Ameren Director Sells Shares Under 10b5-1 Plan

Ameren Director Rafael Flores reported the sale of 225 shares of common stock at $105.21 per share, effective November 17, 2025, under a pre-arranged plan.

Summary

• Rafael Flores, a Director of Ameren Corp (AEE), reported a transaction involving the company's common stock.
• Flores sold 225 shares of Ameren Common Stock, $.01 Par Value, on November 17, 2025.
• The shares were sold at a price of $105.21 per share.
• Following this transaction, Flores beneficially owns 14,173 shares of Ameren common stock.
• The reported amount of beneficially owned shares includes 291 shares acquired through reinvested dividends during the first through third quarters of 2025.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The reported transaction is a director's sale of a small number of shares, but it is explicitly stated to be pursuant to a Rule 10b5-1 plan, which suggests it is a pre-scheduled, routine disposition not based on new material non-public information. The director retains a significant beneficial ownership and has also acquired shares through dividend reinvestment, indicating continued alignment with shareholder interests.

Positives

• The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on new, non-public information.
• Director Rafael Flores continues to hold a substantial 14,173 shares of Ameren common stock after the reported transaction.
• The director acquired 291 shares through dividend reinvestment during the first three quarters of 2025, indicating ongoing participation in the company's equity.

Negatives

• Director Rafael Flores disposed of 225 shares of common stock.

Future Outlook

NA

Industry Context

This filing reports a routine insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may view the director's sale with slight caution, though the amount is small and executed under a pre-arranged plan, mitigating concerns about opportunistic selling.

Key Dates

Recommendation

The Form 4 reports a director's planned sale of a small number of shares in the future, executed under a Rule 10b5-1 plan. This type of pre-scheduled insider transaction, especially when it represents a minor portion of the director's total holdings and is not indicative of a change in the company's fundamental outlook, typically does not warrant a change in investment recommendation. The director still retains a substantial stake, and the filing itself does not contain new information about the company's operational or financial performance.

Keywords

Ameren, AEE, Rafael Flores, insider trading, Form 4, director, stock sale, beneficial ownership, 10b5-1 plan